Novelix Pharmaceuticals Schedules 32nd AGM and Issues FY26 Annual Report Access Notice
Novelix Pharmaceuticals Ltd 路 Annual General Meeting 路 08 Sept 2026, 3:52 am
Novelix Pharmaceuticals Schedules 32nd AGM and Issues FY26 Annual Report Access Notice Novelix Pharmaceuticals Limited will convene its 32nd Annual General Meeting on 30th Sep'26 at 3:00 PM IST via video conferencing and audio-visual means. Pursuant to SEBI Listing Regulations, the company issued web access details for its FY26 Annual Report and AGM Notice to shareholders without registered email addresses. The company also reminded physical security holders to complete mandatory KYC updates鈥攊ncluding PAN, bank details, and nominations鈥攁nd encouraged dematerialization of shares in compliance with SEBI directives through its Registrar and Share Transfer Agent, Venture Capital and Corporate Investments.
Original exchange filing (PDF)
More announcements from Novelix Pharmaceuticals Ltd
- Submission of Intimation of Corporate office opening. 路 18 Nov 2026
- Submission of Supply agreement intimation. 路 13 Nov 2026
- Submission of intimation of change in Designation of Director. 路 12 Nov 2026
- Attached as per above Subject. 路 12 Nov 2026
- Submission of unaudited financial results for the quarter and half year ended September, 2026. 路 12 Nov 2026
- Submission of outcome of the Board Meeting. 路 12 Nov 2026
- Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve unaudited standalone .... 路 11 Nov 2026
- Attached 路 03 Oct 2026
